E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/7/2015 in the Prospect News Bank Loan Daily.

Genoa sets price talk in $420 million term loans, moves up timing

By Paul A. Harris

Portland, Ore., April 7 – Genoa, a QUO Healthcare Co., LLC set price talk for its $420 million credit facility, according to a market source.

A $265 million seven-year first-lien covenant-light term loan is talked at Libor plus 425 basis points with a 1% Libor floor at 99. It comes with six-month soft call protection at 101.

A $155 million eight-year second-lien covenant-light term loan is talked at Libor plus 850 bps with a 1% Libor floor at 99, with hard calls at 102 in year one and 101 in year two.

The commitment date was moved ahead to April 17 from April 21.

Credit Suisse Securities (USA) LLC is leading the $470 million facility, which also includes a $50 million revolver.

Credit ratings remain to be determined.

Proceeds will be used to fund the LBO of the Gresham, Ore.-based behavioral health specialty pharmacy company by Advent International and Nautic Partners.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.